Agilent Completes Acquisition of Biocare Medical
Agilent Technologies Inc. has completed its acquisition of Biocare Medical for $950 million, expanding its pathology portfolio and enhancing its ability to serve customers in clinical and research settings. Biocare Medical specializes in pathology products for cancer diagnosis, including immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) techniques. This strategic move aims to strengthen Agilent's capabilities and accelerate customer-centric innovation in the diagnostics market.
Tela™ agentic AI assistant
The Tela agentic AI assistant, developed for the energy industry, integrates domain expertise, workflow intelligence, and agentic AI to enhance operations. It automates tasks, coordinates complex workflows, and provides proactive insights across subsurface, drilling, production, and sustainability. This aims to improve efficiency, reliability, and decision-making for energy teams.
Coca-Cola Meets Sympathetic Judges in Transfer Pricing Dispute
A federal appellate court panel showed sympathy toward Coca-Cola's arguments in a major transfer pricing dispute with the IRS, which could result in billions in taxes and penalties for the soft drink giant. The judges questioned the IRS's methods, particularly concerns about retroactivity and the application of new tax calculation methods. This case also involves the Supreme Court’s Loper Bright ruling, regarding judicial deference to agency interpretations, and the concept of "blocked income" from foreign affiliates.
Tenaris plans $90M upgrade to Pennsylvania facilities
Tenaris is investing over $90 million to modernize its steel shop and scrap processing facility in Koppel, Pa., and its seamless pipe manufacturing plant in Ambridge, Pa. The upgrades, focusing on automation and production efficiency, will increase the Koppel electric-arc furnace's capacity and add a steel bar yard, with projects expected to continue into the second half of 2027. This investment aims to meet the growing demand for American energy and reinforce Tenaris's position as a reliable partner for U.S. operators.
Telos stock falls as director sells shares
Telos Corp (NASDAQ:TLS) shares fell 5% after director Bradley W. Jacobs sold 55,772 shares of common stock. The sales occurred on June 22 at a weighted average price of $4.31 per share, with transactions ranging from $4.21 to $4.56. Following the sale, Jacobs retains 166,612 shares.
Telos stock falls as director sells shares By Investing.com
Telos Corp (NASDAQ:TLS) shares dropped 5% after director Bradley W. Jacobs sold 55,772 shares of common stock at a weighted average price of $4.31 per share. The transactions, ranging from $4.21 to $4.56, leave Jacobs with 166,612 shares directly held. This insider stock sale was disclosed in a Form 4 filing with the SEC and contributed to the stock's decline.
PepsiCo is tipped by Evercore to miss Q2 earnings expectations (PEP:NASDAQ)
Evercore ISI suggests that PepsiCo (PEP) is likely to miss its Q2 earnings expectations. Analyst Robert Ottenstein's team projects an organic sales growth of +2.3% for Q2, which is below the +2.8% consensus among analysts. PepsiCo is set to report its earnings in two weeks.
Looking for anti-Prime Day deals? Target has $100 off a cordless vacuum
Target's Circle Deal Days are running concurrently with Prime Day, offering significant discounts. A standout deal is $100 off the Levoit VortexIQ Pro Cordless Stick Vacuum, bringing its price under $200. This lightweight vacuum features NeoSight Dust Detection, TripleStrike Technology, powerful suction with HEPA filtration, and a convenient cordless design with up to 60 minutes of battery life.
Agilent completes $950 million Biocare acquisition
Agilent Technologies has successfully completed its $950 million acquisition of Biocare Medical, integrating the clinical pathology company into its Life Sciences and Diagnostics Markets Group. This strategic move is anticipated to boost Agilent's top-line growth rate, margin profile, and non-instrument revenue mix, with accretion to EPS expected approximately 12 months after closing. The acquisition expands Agilent's pathology portfolio and strengthens its diagnostics business with new clinical and research pathology products.
How AmEx's Latest SMB Partnership Fits Its Long-Term Growth Strategy
American Express (AmEx) has unveiled a new partnership with Mercantile and the American Bar Association (ABA) to offer a co-branded business card tailored for solo practitioners and small law firms. This initiative, issued by Celtic Bank and leveraging AmEx's network, aims to expand AmEx's commercial payments business by targeting specialized professional segments. While not expected to significantly impact near-term earnings, the partnership aligns with AmEx's long-term strategy to grow its premium commercial card portfolio and deepen customer relationships, facing competition from Mastercard and Visa in the SMB space.